2020Bioventures is a pharmaceutical company dedicated to the development of novel and transformative biodegradable, sustained release micro particle technologies to deliver a range of encapsulated small molecule drugs, proteins and biologics, to virtually any site in the body. Our primary focus is to develop novel drug delivery modes for products targeting rare and ultra-rare diseases.
Currently, 2020Bioventures is advancing a significant portfolio of clinical programs for ophthalmological indications for which we are continuously evaluating partnership opportunities.
At 2020Bioventures, we strive to find life changing therapeutic solutions for patients afflicted by serious or life threatening disease conditions. We believe that every patient deserves safe & effective treatment of his or her condition, regardless of its rarity.